Sand Grove Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Sand Grove Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-537,060	Closed	-$17.8M	–	38
2022 Q4	$17.8M	Buy	+537,060	New	+$17.3M	1.71%	18

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sand Grove Capital Management's VIVO Position: Q1 2023 in Review

Sand Grove Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 537,060 shares — an estimated $17.8M sold.

Sand Grove Capital Management first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $17.8M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Sand Grove Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Sand Grove Capital Management sold 537,060 Meridian Bioscience Inc shares in Q1 2023, an estimated $17.8M.
Sand Grove Capital Management first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Sand Grove Capital Management's Meridian Bioscience Inc position peaked at $17.8M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Sand Grove Capital Management's 13F filing for Q1 2023, filed 15 May 2023.